Pharmaceuticals Research on the use of psychedelics in substance abuse treatment is on the rise Last updated: August 28, 2024 4:44 pm By bexib 0 Min Read Share SHARE A new grant from the National Institutes of Health will advance research into the role of serotonin 5-HT2A receptors in reducing methamphetamine use. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Moral equality and emergent morality Next Article FedNow nears 1,000 financial institutions joining Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Data suggests a strong holiday season in 2024 Retail & E-commerce Signicat uses AsiaVerify to strengthen identity verification in APAC Fintech Singapore Gulf Bank aims to raise up to $50 million to acquire stablecoin company Fintech Utrip raises Series C ahead of planned IPO, listing still ‘several years’ away Fintech